يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Bart A. van de Wiel"', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study

    المؤلفون: Bernies van der Hiel, John B.A.G. Haanen, Marcel P.M. Stokkel, Daniel S. Peeper, Connie R. Jimenez, Jos H. Beijnen, Bart A. van de Wiel, Ronald Boellaard, Alfons J.M. van den Eertwegh, REPOSIT study group

    المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)

    مصطلحات موضوعية: Stage IIIc/IV melanoma, Resistance, BRAF inhibitor, MEK inhibitor, 18F-FDG, 18F-FLT, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-017-3626-5Test; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/77ba6f1ed208421eb8ac731a793a38eaTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial

    المؤلفون: Michel W.J.M. Wouters, Sandra Adriaansz, Christian U. Blank, Bernies van der Hiel, Willem M.C. Klop, Bart A. van de Wiel, Johannes V. Van Thienen, Stephanie A. Blankenstein, Karolina Sikorska, Harm van Tinteren, Maartje W. Rohaan, Alexander C.J. van Akkooi, Winan J. van Houdt, Sofie Wilgenhof, Max J. Lahaye, A. Sari, Lindsay G Grijpink-Ongering, John B. A. G. Haanen

    المصدر: Annals of Surgery, 274(2), 383-389. LIPPINCOTT WILLIAMS & WILKINS

    مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, medicine.medical_treatment, unresectable, Pyrimidinones, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, Oximes, medicine, Humans, Stage IIIC, Prospective Studies, Melanoma, Cancer staging, Aged, Neoplasm Staging, Netherlands, Trametinib, business.industry, neoadjuvant, MEK inhibitor, Imidazoles, Dabrafenib, Cytoreduction Surgical Procedures, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Neoadjuvant Therapy, BRAF mutation, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Surgery, Female, Radiology, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c8330f3776251538255964ce6c8db0Test
    https://pubmed.ncbi.nlm.nih.gov/33843797Test


    أضف إلى المفضلة
  3. 3
    Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection: REDUCTOR trial

    المؤلفون: W. Martin C. Klop, Bart A. van de Wiel, John B. A. G. Haanen, Daniel S. Peeper, Bernies van der Hiel, Maartje W. Rohaan, Alexander C.J. van Akkooi, Stephanie A. Blankenstein

    المصدر: Journal of Clinical Oncology. 37:9587-9587

    مصطلحات موضوعية: Surgical resection, Oncology, Trametinib, Cancer Research, medicine.medical_specialty, business.industry, MEK inhibitor, Dabrafenib, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Potency, business, 030215 immunology, medicine.drug, Advanced melanoma

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d82f3ec4b3143371c96c9c8510a857e6Test
    https://doi.org/10.1200/jco.2019.37.15_suppl.9587Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث